Intervention not reported
Stillbirth · HIV‐positive women during pregnancy and immediate postpartum period
It is very uncertain whether the intervention changes stillbirth (very low certainty).
1 finding from 1 review
Intervention not reported
Maternal death · HIV‐positive women during pregnancy and immediate postpartum period
It is very uncertain whether the intervention changes maternal death (very low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality: longest · infants 1 to 6 months of age
The intervention showed no clear difference in all‐cause mortality: longest (moderate certainty).
1 finding from 1 review
Intervention not reported
Morbidity: diarrhoea: point prevalence · infants 1 to 6 months of age
The intervention showed no clear difference in morbidity: diarrhoea: point prevalence (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: bulging fontanelle within 48 to 72 hours · infants 1 to 6 months of age
The intervention leads to higher adverse effects: bulging fontanelle within 48 to 72 hours (high certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: vomiting 48 to 72 hours · infants 1 to 6 months of age
The intervention showed no clear difference in adverse effects: vomiting 48 to 72 hours (low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: diarrhoea 48 to 72 hours · infants 1 to 6 months of age
The intervention showed no clear difference in adverse effects: diarrhoea 48 to 72 hours (low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: fever 48 to 72 hours · infants 1 to 6 months of age
The intervention showed no clear difference in adverse effects: fever 48 to 72 hours (low certainty).
1 finding from 1 review
Eclampsia · pregnant women, either during the prenatal period or during labour.
1 finding from 1 review
Pre‐eclampsia · pregnant women, either during the prenatal period or during labour.
Pyridoxine (B6) showed no clear difference in pre‐eclampsia ‐ Antenatal oral pyridoxine versus control compared with control (low certainty).
2 findings from 1 review
Dental caries · pregnant women, either during the prenatal period or during labour.
Pyridoxine (B6) may leads to lower dental decay (increase in decayed, missing or filled teeth) ‐… compared with control (low certainty).
1 finding from 1 review
Dental decay (increase in decayed, missing or filled teeth) ‐ Antenatal pyridoxine lozenges versus control · pregnant women, either during the prenatal period or during labour.
Pyridoxine (B6) may leads to lower dental decay (increase in decayed, missing or filled teeth) ‐… compared with control (low certainty).
1 finding from 1 review
Preterm birth · pregnant women, either during the prenatal period or during labour.
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Low birthweight · pregnant women, either during the prenatal period or during labour.
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Intervention not reported
Preterm birth · Pregnant women
The intervention showed no clear difference in preterm birth (low certainty).
1 finding from 1 review
Intervention not reported
Maternal mortality · Pregnant women
1 finding from 1 review
Intervention not reported
Perinatal mortality · Pregnant women
The intervention showed no clear difference in perinatal mortality (low certainty).
1 finding from 1 review
Intervention not reported
Maternal anaemia · Pregnant women
The intervention showed no clear difference in maternal anaemia (low certainty).
1 finding from 1 review
Intervention not reported
Maternal clinical infection · Pregnant women
The intervention showed no clear difference in maternal clinical infection (low certainty).
1 finding from 1 review
Intervention not reported
Incidence of recurrent VTE · patients with venous thromboembolism
The intervention leads to lower incidence of recurrent VTE (high certainty).
1 finding from 1 review